Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D

Slides:



Advertisements
Similar presentations
Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study  Thi.
Advertisements

Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection.
Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation.
Karl R. Hansen, M. D. , Ph. D. , George M. Hodnett, M. D
The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Letrozole administration during the luteal phase after ovarian stimulation impacts corpus luteum function: a randomized, placebo-controlled trial  Juan.
Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase  Michael von Wolff, M.D., Christian J. Thaler,
Michael M. Alper, M.D.  Fertility and Sterility 
Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis 
Janet Kwee, M. D. , Roel Schats, M. D. , Ph. D. , Joseph McDonnell, M
The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation.
Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles  Angela R. Baerwald, Ph.D.,
Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization.
Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.
Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective randomized study  Leonidas Mamas, M.D., Ph.D. 
Medical treatment of ectopic pregnancy: a committee opinion
Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization.
Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers  Andrea.
Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm.
Antral follicle count: absence of significant midlife decline
The role of steroid hormone supplementation in non–assisted reproductive technology treatments for unexplained infertility  Alexander M. Quaas, M.D.,
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
Triploidy formation after intracytoplasmic sperm injection may be a surrogate marker for implantation  Mitchell P. Rosen, M.D., Shehua Shen, M.D., Anthony.
A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data 
Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.
Prospective evaluation of luteal phase length and natural fertility
Oocyte cryopreservation
Mitchell P. Rosen, M. D. , Shehua Shen, M. D. , Charles E
Deleterious effect of tobacco on IVF outcome and ovarian reserve as reflected by serum anti mullerian hormone (AMH)  P. Barriere, T. Freour, D. Masson,
Angela R. Baerwald, Ph. D. , Olufemi A. Olatunbosun, M. D. , Roger A
Robert F. Casper, M.D.  Fertility and Sterility 
Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study  Ahmet Erdem, M.D., Mehmet Erdem,
Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling.
A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone 
Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis  Laura P. Smith, M.D.,
Plasma matrix metalloproteinase activity during the menstrual cycle of healthy ovulatory patients who underwent tubal ligation  Maher A. Abdallah, M.D.,
Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation  Nam D. Tran, M.D., Ph.D., Lusine Aghajanova, M.D.,
Tomer Singer, M. D. , David H. Barad, M. D. , M. S
Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility  Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,
Clomiphene citrate at 50: the dawning of assisted reproduction
Mitchell P. Rosen, M. D. , Erica Johnstone, M. D. , Charles E
Synchronization of ovarian stimulation with follicle wave emergence in patients undergoing in vitro fertilization with a prior suboptimal response: a.
Introduction Fertility and Sterility
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Effect of letrozole at 2. 5 mg or 5
Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study  Carlo.
Fresh autologous transplantation of ovarian cortical strips to the anterior abdominal wall at the pfannenstiel incision site  Gurkan Kiran, M.D., Hakan.
Effectiveness of highly purified human menopausal gonadotropin vs
S. Samuel Kim, M.D.  Fertility and Sterility 
Heterotopic autotransplantation of cryobanked human ovarian tissue as a strategy to restore ovarian function  S.Samuel Kim, M.D., In-Tak Hwang, M.D.,
Fertility and Sterility: an evaluation
Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify.
Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.
Sedigheh Borna, M.D., Azita Nasery, M.D.  Fertility and Sterility 
Impact of leuprolide acetate on luteal phase function in women undergoing controlled ovarian hyperstimulation and intrauterine insemination  Deirdre A.
Current evaluation of amenorrhea
The play of chance Fertility and Sterility
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
Serum anti-Mullerian hormone dynamics during stimulated cycles by aromatase inhibitor anastrozole and clomiphene citrate in women with infertility  H.-H.
Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study  Ahmed Badawy, M.D., Aboubakr.
Cem Fiçicioǧlu, M. D. , Tayfun Kutlu, M. D. , Elif Baglam, M. D
Defining the proliferative phase endometrial defect
In vitro sildenafil citrate use as a sperm motility stimulant
Daniel R. Grow, M.D., Khosro Iromloo, M.D.  Fertility and Sterility 
Ovarian follicular volume and follicular surface area are better indicators of follicular growth and maturation, respectively, than is follicular diameter 
Ongoing pregnancy rates in intrauterine insemination are affected by late follicular- phase progesterone levels  Antonio Requena, M.D., María Cruz, Ph.D.,
A novel “delayed start” protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders  Hakan Cakmak, M.D., Nam D. Tran,
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three- dimensional ultrasound determinants of ovarian reserve in the prediction.
Presentation transcript:

Effective method for emergency fertility preservation: random-start controlled ovarian stimulation  Hakan Cakmak, M.D., Audra Katz, R.N., Marcelle I. Cedars, M.D., Mitchell P. Rosen, M.D.  Fertility and Sterility  Volume 100, Issue 6, Pages 1673-1680 (December 2013) DOI: 10.1016/j.fertnstert.2013.07.1992 Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Representative serum hormone profiles and follicle development patterns in (A) conventional early follicular phase– and random ([B, C] late follicular– and [D, E] luteal phase–) start controlled ovarian stimulation cycles. Fertility and Sterility 2013 100, 1673-1680DOI: (10.1016/j.fertnstert.2013.07.1992) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.